Shares of Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) dropped 1.1% on Wednesday . The company traded as low as $3.09 and last traded at $3.09. Approximately 1,150 shares changed hands during trading, an increase of 30% from the average daily volume of 887 shares. The stock had previously closed at $3.12.
SPHDF has been the topic of a number of recent research reports. Credit Suisse Group reaffirmed a “neutral” rating on shares of Santhera Pharmaceuticals in a research report on Friday, November 6th. CSFB raised Santhera Pharmaceuticals from an “underperform” rating to a “neutral” rating in a report on Tuesday, October 6th.
The company’s 50-day moving average is $3.14.
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. It is developing Duchenne muscular dystrophy (DMD) product portfolio to treat patients irrespective of causative mutations, disease stage, or age.
Featured Article: CBOE Russell 2000® Volatility Index
Receive News & Ratings for Santhera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santhera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.